Lai X, Qiao J, Liu J, Zhou X, Zhang C, Peng Q. Albumin as a functional carrier enhances solubilization, photodynamic and photothermal antibacterial therapy of curcumin.
Int J Biol Macromol 2025;
303:140759. [PMID:
39919397 DOI:
10.1016/j.ijbiomac.2025.140759]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2025] [Revised: 02/04/2025] [Accepted: 02/05/2025] [Indexed: 02/09/2025]
Abstract
Bacterial infections are a significant threat to human health. Photodynamic therapy (PDT) and photothermal therapy (PTT) offer promising alternatives to antibiotic therapy. Curcumin (CUR) has shown great potentials in PDT, but its PTT was never reported. Also, its delivery and efficacy is highly limited by the poor water solubility. Herein, we report the antibacterial PTT of CUR for the first time. Furthermore, we successfully solubilized CUR, facilitated its delivery into bacterial cells, and enhanced its antibacterial PDT/PTT via using bovine serum albumin (BSA) as a carrier. The water solubility of CUR was enhanced from 10 to 298 μg/mL by forming CUR-BSA complex (containing 4 mg/mL BSA) which also enhanced the delivery of CUR into E. coli cells by >10 folds. Upon 450 nm irradiation, CUR-BSA (80 μg/mL) caused 94 % viability loss of E. coli, higher than 70 % loss caused by CUR, and more intracellular ROS was generated in CUR-BSA group. Interestingly, the antibacterial activity of CUR-BSA was reduced when the hyperthermia was depleted, suggesting its synergistic PDT/PTT effect. Considering the ready availability and great biocompatibility of albumin, our findings indicate that CUR-albumin complex may have great potentials in clinical use for antibacterial phototherapy.
Collapse